cbdMD, Inc.YCBDNYSE
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank66
5Y CAGR-23.3%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-23.3%/yr
Long-term compound
Percentile
P66
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 9.57% |
| Q3 2025 | -1.40% |
| Q2 2025 | -4.58% |
| Q1 2025 | -13.83% |
| Q4 2024 | 30.48% |
| Q3 2024 | -23.68% |
| Q2 2024 | 36.05% |
| Q1 2024 | -30.05% |
| Q4 2023 | 19.46% |
| Q3 2023 | -21.02% |
| Q2 2023 | -4.56% |
| Q1 2023 | 13.96% |
| Q4 2022 | -29.31% |
| Q3 2022 | -17.90% |
| Q2 2022 | -2.83% |
| Q1 2022 | 21.58% |
| Q4 2021 | -14.55% |
| Q3 2021 | -21.58% |
| Q2 2021 | -12.28% |
| Q1 2021 | -8.66% |
| Q4 2020 | 36.12% |
| Q3 2020 | -7.59% |
| Q2 2020 | 3.32% |
| Q1 2020 | 3.40% |
| Q4 2019 | 25.61% |
| Q3 2019 | 1.12% |
| Q2 2019 | 36.38% |
| Q1 2019 | 1139.81% |
| Q4 2018 | -52.98% |
| Q3 2018 | -69.48% |
| Q2 2018 | -18.20% |
| Q1 2018 | 456.33% |
| Q4 2017 | -15.93% |
| Q3 2017 | -64.16% |
| Q2 2017 | 51.03% |
| Q1 2017 | 2623.44% |
| Q4 2016 | 126.64% |
| Q3 2016 | -317.07% |
| Q2 2016 | 0.00% |